Race Oncology Management
Management criteria checks 2/4
Race Oncology's CEO is Daniel Tillett, appointed in Nov 2023, has a tenure of less than a year. total yearly compensation is A$835.75K, comprised of 39.8% salary and 60.2% bonuses, including company stock and options. directly owns 9.84% of the company’s shares, worth A$21.30M. The average tenure of the management team and the board of directors is 0.7 years and 3.5 years respectively.
Key information
Daniel Tillett
Chief executive officer
AU$835.7k
Total compensation
| CEO salary percentage | 39.8% |
| CEO tenure | less than a year |
| CEO ownership | 9.8% |
| Management average tenure | less than a year |
| Board average tenure | 3.5yrs |
Recent management updates
Recent updates
We're Not Very Worried About Race Oncology's (ASX:RAC) Cash Burn Rate
Jan 23
Here's Why We're Not Too Worried About Race Oncology's (ASX:RAC) Cash Burn Situation
Oct 05Companies Like Race Oncology (ASX:RAC) Are In A Position To Invest In Growth
Jun 20We're Interested To See How Race Oncology (ASX:RAC) Uses Its Cash Hoard To Grow
Feb 17Here's Why We're Not At All Concerned With Race Oncology's (ASX:RAC) Cash Burn Situation
Oct 14Here's Why We're Not Too Worried About Race Oncology's (ASX:RAC) Cash Burn Situation
Apr 01We're Hopeful That Race Oncology (ASX:RAC) Will Use Its Cash Wisely
Apr 05What Percentage Of Race Oncology Limited (ASX:RAC) Shares Do Insiders Own?
Mar 01How Much Are Race Oncology Limited (ASX:RAC) Insiders Taking Off The Table?
Jan 07
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | -AU$11m |
| Sep 30 2023 | n/a | n/a | -AU$11m |
| Jun 30 2023 | AU$836k | AU$332k | -AU$10m |
| Mar 31 2023 | n/a | n/a | -AU$10m |
| Dec 31 2022 | n/a | n/a | -AU$11m |
| Sep 30 2022 | n/a | n/a | -AU$11m |
| Jun 30 2022 | AU$1m | AU$228k | -AU$11m |
| Mar 31 2022 | n/a | n/a | -AU$10m |
| Dec 31 2021 | n/a | n/a | -AU$9m |
| Sep 30 2021 | n/a | n/a | -AU$8m |
| Jun 30 2021 | AU$1m | AU$167k | -AU$6m |
| Mar 31 2021 | n/a | n/a | -AU$5m |
| Dec 31 2020 | n/a | n/a | -AU$4m |
| Sep 30 2020 | n/a | n/a | -AU$4m |
| Jun 30 2020 | AU$147k | n/a | -AU$4m |
Compensation vs Market: Daniel's total compensation ($USD539.12K) is above average for companies of similar size in the Australian market ($USD289.12K).
Compensation vs Earnings: Daniel's compensation has been consistent with company performance over the past year.
CEO
Daniel Tillett
less than a year
Tenure
AU$835,747
Compensation
Dr. Daniel Tillett serves as Chief Executive Officer of Race Oncology Limited since November 22, 2023. He served as Non-Executive Director at Simble Solutions Limited since February 16, 2022 until July 03,...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chief Executive Officer | less than a year | AU$835.75k | 9.84% A$ 21.3m | |
| Executive Director | less than a year | AU$635.00 | no data | |
| Chief Financial Officer | less than a year | no data | no data | |
| Interim Chief Scientific Officer | 1.1yrs | no data | no data | |
| Chief Medical Officer | less than a year | no data | no data | |
| Company Secretary | 7.9yrs | no data | no data |
0.7yrs
Average Tenure
Experienced Management: RAC's management team is not considered experienced ( 0.7 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Director | less than a year | AU$635.00 | no data | |
| Member of Scientific Advisory Board | 7.3yrs | no data | no data | |
| Non-Executive Director | 3.8yrs | AU$715.00k | 0.26% A$ 560.0k | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Chairman of Clinical Advisory Board | 4.3yrs | AU$815.36k | no data | |
| Member of Clinical Advisory Board | 4.2yrs | no data | no data | |
| Independent Non-Executive Chair | 3.2yrs | AU$148.56k | 0.014% A$ 30.5k | |
| Member of Scientific Advisory Board | 3yrs | no data | no data | |
| Member of Scientific Advisory Board | 1.9yrs | no data | no data |
3.5yrs
Average Tenure
Experienced Board: RAC's board of directors are considered experienced (3.5 years average tenure).